New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals today posted a nearly 4% increase in its net profit to Rs128.9 crore in the quarter-ended 30 June 2010, over the same period last year.
The company had a net profit of Rs124.35 crore in the corresponding period last year, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
During the quarter, net sales of the company stood at Rs497.93 crore, a 9% increase from Rs457.41 crore registered in the same period previous year.
“Sales of pharmaceuticals were adversely impacted on account of constraints on vaccine supply during the quarter,” the company said.
In the six-months ended 30 June 2010, the company’s net profit stood at Rs290.18 crore, as against Rs267.62 crore recorded in the corresponding period last year.
During the period, GlaxoSmithKline Pharmaceuticals had a net sales of Rs1,039.03 crore, as against Rs914.56 crore posted in the year ago-period.